Cipla Introduces Afrezza - Ultra-Rapid Acting Inhaled Insulin for Adults with Diabetes in India Dr. Bhumika Maikhuri16 March 2026 11:45 AM ISTCipla Limited has announced the launch of Afrezza, the world's only available inhaled insulin for adults living with Diabetes Mellitus, offering a...
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for Diabetes Parthika Patel13 March 2026 11:28 PM ISTNew Delhi: Biocon Limited's wholly owned subsidiary Biocon Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for...
Sanofi's Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues Alert Susmita Roy5 March 2026 10:00 PM ISTNew Delhi: India's apex drug regulator, the Central Drugs Standard Control Organization (CDSCO), has issued a public advisory following the reported...
Natco Pharma Gets Court Nod to Make, Export Semaglutide for Diabetes and Obesity Markets Susmita Roy10 Feb 2026 7:32 PM ISTNew Delhi: Natco Pharma has secured regulatory clearance from the High Court to manufacture semaglutide and export the drug to select international...
Online Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts sheeba farhat9 Jan 2026 11:28 PM ISTBengaluru: Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic,...
WHO Issues First Global Guideline on Diabetes in Pregnancy on World Diabetes Day 2025: Key Takeaways Dr. Kamal Kant Kohli26 Nov 2025 12:15 PM ISTThe World Health Organization (WHO) has issued its first global guideline for diabetes in pregnancy on World Diabetes Day (November 14, 2025), and the...
Dapagliflozin and Sitagliptin FDC: Exploring Early Initiation Benefits In Young Newly Diagnosed T2D in India Dr. Rajiv Kovil1 Nov 2025 10:34 AM ISTType 2 diabetes (T2D) is a growing epidemic in India. India has 101 million people with diabetes and 136 million with prediabetes, with disease onset...
Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Farhat Nasim24 Oct 2025 11:36 AM ISTNew Delhi: In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla...
Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study Deeksha Bhandari8 Sept 2025 12:00 PM ISTA real-world Indian study found that glipizide, alone or with metformin, improves glycemic control in patients with declining renal function without...
Novo Nordisk to Discontinue Multiple rDNA Insulin Products in India Parthika Patel4 Sept 2025 3:03 PM ISTThe CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are available in Indian...
Novo Nordisk's Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert Susmita Roy23 Aug 2025 3:00 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has issued an alert for doctors and healthcare professionals to carefully prescribe and...
The Prediabetes Show - Episode 1: Reversing Prediabetes - Myth or Fact? Deeksha Bhandari7 Aug 2025 9:00 AM ISTPresenting Episode 1 of the Prediabetes Show: "Reversing Prediabetes-Myth or Fact?" In this Dr. Ganesh H K, Consultant Endocrinologist from Mangalore,...
